The RANKL inhibitor OPG-Fc increases cortical and trabecular bone mass in young gonad-intact cynomolgus monkeys
- 24 March 2007
- journal article
- research article
- Published by Springer Nature in Osteoporosis International
- Vol. 18 (8) , 1073-1082
- https://doi.org/10.1007/s00198-007-0363-7
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- RANKL is a Marker and Mediator of Local and Systemic Bone Loss in Two Rat Models of Inflammatory ArthritisJournal of Bone and Mineral Research, 2005
- Osteoclastogenesis Inhibitory Factor/Osteoprotegerin Reduced Bone Loss Induced by Mechanical UnloadingCalcified Tissue International, 2004
- Osteoprotegerin Regulates Bone Formation through a Coupling Mechanism with Bone ResorptionEndocrinology, 2003
- A Phase I study of AMGN-0007, a recombinant osteoprotegerin construct, in patients with multiple myeloma or breast carcinoma related bone metastasesCancer, 2003
- OPG and PTH-(1–34) Have Additive Effects on Bone Density and Mechanical Strength in Osteopenic Ovariectomized RatsEndocrinology, 2001
- Nonhuman primate models in skeletal researchBone, 2001
- The Effect of a Single Dose of Osteoprotegerin in Postmenopausal WomenJournal of Bone and Mineral Research, 2001
- The Ligand for Osteoprotegerin (OPGL) Directly Activates Mature OsteoclastsThe Journal of cell biology, 1999
- Osteoprotegerin: A Novel Secreted Protein Involved in the Regulation of Bone DensityCell, 1997
- Mechanical validation of a tomographic (pQCT) index for noninvasive estimation of rat femur bending strengthBone, 1996